Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$0.4882 -2.36%
Market Cap
$118.9M
Price Target
Refer to Report
Volume
3.1M
52wk Range
$0.1611 - $2.5375
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.